Thursday 30 January
Please note that this is the preliminary programme; times and titles are still subject to change.
08.30 - 09.00 | Plenary III - Alpha-synuclein seeding assays
Alison Green (Edinburgh, UK)
Chairs: Kathleen Poston (San Fransisco, USA) & Glenda Halliday (Sydney, Australia)
09.00 - 09.30 | Plenary IV - Co-pathology in DLB
David Irwin (Philadelphia, USA) More information >
Chairs: Kathleen Poston (San Fransisco, USA) & Glenda Halliday (Sydney, Australia)
09.30 - 09.45 | SHORT BREAK
09.45 - 11.15 | Symposium IV - Fluid biomarkers
Chairs: Charlotte Teunissen (Amsterdam, NL) & Brit Mollenhauer (Goettingen, Germany)
- DOPA Decarboxylase: High discriminative power in CSF, but confounded by treatment in blood, Katharina Bolsewig (Amsterdam, NL)
- Predicting Dementia in Parkinson’s Disease: Insights from α-Synuclein SAA, NfL, Aβ, and GCase Biomarkers, Jodi Maple-Grødem (Stavanger, Norway)
- Diagnostic accuracy of plasma biomarkers for detecting amyloidosis in alpha-synucleinopathies, Carla Abdelnour (San Fransisco, USA)
- Differential Associations of plasma NfL and Cognitive Performance in Lewy Bodies Disease Patients with and without Alzheimer’s Disease Co-Pathology, Elena Vera Campuzano (Barcelona, Spain)
- The US Dementia with Lewy Bodies Consortium: Description and Insights on the Performance of CSF Synuclein Aggregation Assay, James Leverenz (Cleveland, USA)
- Protein panels for accurate diagnosis and monitoring of treatment responses in DLB, Charlotte Teunissen (Amsterdam, NL)
11.15 - 11.45 | COFFEE BREAK
11.45 - 13.15 | Symposium V - Imaging/neurophysiology Biomarkers
Chairs: Laura Bonanni (Chieti, Italy) & Daniel Ferreira (Stockholm, Sweden)
Oral presentations
- Imaging biomarkers of neurodegeneration in the DLB spectrum, Kejal Kantarci (Rochester, USA)
- Prediction of phenoconversion in isolated REM sleep behavior disorder using free water imaging: a longitudinal, multicentre, prospective cohort study, Shady Rahayel (Montreal, Canada)
- Increased functional coupling of EEG pre-alpha rhythms in patients with Dementia with Lewy Bodies, Anita D'Anselmo (Chieti, Italy)
- The dementia with Lewy bodies related metabolic brain pattern expression in patients with dementia with Lewy bodies, Alzheimer dementia and Parkinson disease dementia: a multicentric study, Matej Perovnik (Ljubljana, Slovenia)
- Glymphatic dysfunction contributes to development of cognitive impairment in Parkinson’s independently from white matter degeneration, Angeliki Zarkali (London, UK)
- Pathways for the progression of neurodegeneration in dementia with Lewy bodies, Bastiaan van Tol (Stockholm, Sweden)
13.15 - 14.30 | LUNCH/Poster session/Multiple trailer showings of Facing the Wind, a new documentary film sponsored by LBD Resource Center More information>
14.30 - 16.00 | Symposium VI - Biological classification and LBD
Chairs: James Leverenz (Cleveland, USA) & John-Paul Taylor (Newcastle, UK)
- NSD-ISS
Tatyana Simuni (Chicago, USA) - SyNeurGe
Anthony Lang (Toronto, Canada) - ATN-classification, lessons learned from Alzheimer’s disease
Philip Scheltens (Amsterdam, NL) - DLB & biological classification schemes
Bradley Boeve (Rochester, USA)
16.00-16.15 | SHORT BREAK
16.15-17.15 | Panel discussion
Chairs: James Leverenz (Cleveland, USA) & John-Paul Taylor (Newcastle, UK)
Panel: Tatyana Simuni (Chicago, USA), Anthony Lang (Toronto, Canada), Philip Scheltens (Amsterdam, NL), Bradley Boeve (Rochester, USA), David Burn (MDS), Jennifer Goldman, Angela Taylor (LBDA), Glenda Halliday